It was arguable how much value GW actually provided and I am not singling him out for special mention.
Just saying GW was a marketing guy and did not have the persona as Dame Louise Makin at BTG, Pascal Soriot at Astra Zeneca or Werner Baumann at Bayer or even Vigodman at Teva (Cephalon) but then again BTG, Astra and Bayer r much larger companies with far greater stakeholders.
I still think Makin or Soriot or Baumann will still launch in good time. If they launch a bid, there could be a counterbid depending on the results.
Ann: Foreshadowed Federal Court of Australia Proceeding, page-42
-
- There are more pages in this discussion • 22 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SRX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
13.0¢ |
Change
0.005(4.00%) |
Mkt cap ! $55.17M | |||
| Open | High | Low | Value | Volume |
| 12.5¢ | 13.5¢ | 12.5¢ | $381.8K | 2.877M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 350931 | 13.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 13.5¢ | 297464 | 5 |
View Market Depth
| Last trade - 16.10pm 25/06/2024 (20 minute delay) ? |
| SRX (ASX) Chart |